Alcohol dependence Mental and Behavioural Disorders Mental and behavioural disorders due to use of alcohol
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Alcohol dependence according to ICD-10 criteria 2. Male and female, >18 years of age 3. Housing in Stockholm municipality
Exclusion criteria
Exclusion criteria: 1. Extensive social problems 2. Withdrawal symptoms 3. Abuse or dependence of other substances apart from alcohol and/or nicotine 4. Severe psychiatric and/or somatic illness 5. Non-Swedish speaking
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome measures as of 23/08/2013: Change of weekly alcohol consumption measured in grams of alcohol at baseline, defined as 30 days before inclusion, compared to 12 months after start of treatment, defined as 30 days before the 12-month follow-up visit. Comparisons will be made between participants treated in primary care and specialist care. Previous primary outcome measures: 1. Proportion of days with any drinking during treatment and follow-up 2. Proportion of days with heavy drinking during treatment and follow-up Measured at 6 and 12 months following inclusion in study | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 23/08/2013: All with baseline measures compared with measures at follow-up 6 and 12 months after start of treatment in the study, except for the first measure with follow-up 6 months after inclusion in the study. 1. Change of weekly alcohol consumption measured in grams of alcohol 2. Change of days with heavy drinking (cut off women > 3/men >4 standard units with 12 grams of alcohol) per week 3. Change of hazardous and harmful drinking 4. Change of degree of alcohol dependence 5. Change of consequences of drinking 6. Change of symptoms of anxiety and depression 7. Change of quality of life 8. Change of levels of carbohydrate-deficient transferring (CDT) 9. Change of levels of aspartate aminotransferase (AST) 10. Change of levels of alanine aminotransferase (ALT) 11. Change of levels of gamma-glutamyltransferase (GGT) Measure at follow-up 6 and 12 months after start of treatment in the study. 12. Satisfaction with treatment Comparisons will be made between participants treated in primary care and specialist care. Previous secondary outcome measures: 1. Severity of dependence 2. Psychiatric health 3. Percieved quality of life 4. Biological markers Measured at 6 and 12 months following inclusion in study | — |
Countries
Sweden